Ocular Hypotensive Lipids: A Comprehensive Review
Prostaglandin analogs (PGA’s) or ocular hypotensive lipids are a significant class of medications primarily used in the management of glaucoma and ocular hypertension. Since their introduction in the late 20th century, these compounds have revolutionized treatment protocols, offering a potent and ef...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-04-01
|
| Series: | Delhi Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/DLJO.DLJO_91_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849426894291730432 |
|---|---|
| author | Surbi Taneja Harsh Kumar Swati Singh Tripti Johri Anushree Baid |
| author_facet | Surbi Taneja Harsh Kumar Swati Singh Tripti Johri Anushree Baid |
| author_sort | Surbi Taneja |
| collection | DOAJ |
| description | Prostaglandin analogs (PGA’s) or ocular hypotensive lipids are a significant class of medications primarily used in the management of glaucoma and ocular hypertension. Since their introduction in the late 20th century, these compounds have revolutionized treatment protocols, offering a potent and effective means of lowering intraocular pressure (IOP). By mimicking the activity of naturally occurring prostaglandins, these analogs enhance the outflow of aqueous humor from the eye, thus reducing IOP and preventing damage to the optic nerve. Their role in clinical practice has expanded due to their relatively favorable side effect profile and once-daily dosing regimen, which promotes patient adherence. This review article delves into the pharmacodynamics and pharmacokinetics of the PGA’s, including latanoprost, bimatoprost, travoprost, tafluprost, and unoprostone. In addition, this article explores the molecular mechanisms underlying their therapeutic effects, the latest clinical trial data, and comparative studies that highlight their relative benefits and limitations. By synthesizing current knowledge and recent advancements, this article aims to provide a comprehensive overview for healthcare professionals, researchers, and students interested in the evolving landscape of glaucoma treatment. |
| format | Article |
| id | doaj-art-14d6f1be9c174d54a37e0d109df88ada |
| institution | Kabale University |
| issn | 0972-0200 2454-2784 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Delhi Journal of Ophthalmology |
| spelling | doaj-art-14d6f1be9c174d54a37e0d109df88ada2025-08-20T03:29:13ZengWolters Kluwer Medknow PublicationsDelhi Journal of Ophthalmology0972-02002454-27842025-04-013529210210.4103/DLJO.DLJO_91_24Ocular Hypotensive Lipids: A Comprehensive ReviewSurbi TanejaHarsh KumarSwati SinghTripti JohriAnushree BaidProstaglandin analogs (PGA’s) or ocular hypotensive lipids are a significant class of medications primarily used in the management of glaucoma and ocular hypertension. Since their introduction in the late 20th century, these compounds have revolutionized treatment protocols, offering a potent and effective means of lowering intraocular pressure (IOP). By mimicking the activity of naturally occurring prostaglandins, these analogs enhance the outflow of aqueous humor from the eye, thus reducing IOP and preventing damage to the optic nerve. Their role in clinical practice has expanded due to their relatively favorable side effect profile and once-daily dosing regimen, which promotes patient adherence. This review article delves into the pharmacodynamics and pharmacokinetics of the PGA’s, including latanoprost, bimatoprost, travoprost, tafluprost, and unoprostone. In addition, this article explores the molecular mechanisms underlying their therapeutic effects, the latest clinical trial data, and comparative studies that highlight their relative benefits and limitations. By synthesizing current knowledge and recent advancements, this article aims to provide a comprehensive overview for healthcare professionals, researchers, and students interested in the evolving landscape of glaucoma treatment.https://journals.lww.com/10.4103/DLJO.DLJO_91_24antiglaucoma drugsbimatoprostlatanoprostocular hypotensivesprostaglandin analogs |
| spellingShingle | Surbi Taneja Harsh Kumar Swati Singh Tripti Johri Anushree Baid Ocular Hypotensive Lipids: A Comprehensive Review Delhi Journal of Ophthalmology antiglaucoma drugs bimatoprost latanoprost ocular hypotensives prostaglandin analogs |
| title | Ocular Hypotensive Lipids: A Comprehensive Review |
| title_full | Ocular Hypotensive Lipids: A Comprehensive Review |
| title_fullStr | Ocular Hypotensive Lipids: A Comprehensive Review |
| title_full_unstemmed | Ocular Hypotensive Lipids: A Comprehensive Review |
| title_short | Ocular Hypotensive Lipids: A Comprehensive Review |
| title_sort | ocular hypotensive lipids a comprehensive review |
| topic | antiglaucoma drugs bimatoprost latanoprost ocular hypotensives prostaglandin analogs |
| url | https://journals.lww.com/10.4103/DLJO.DLJO_91_24 |
| work_keys_str_mv | AT surbitaneja ocularhypotensivelipidsacomprehensivereview AT harshkumar ocularhypotensivelipidsacomprehensivereview AT swatisingh ocularhypotensivelipidsacomprehensivereview AT triptijohri ocularhypotensivelipidsacomprehensivereview AT anushreebaid ocularhypotensivelipidsacomprehensivereview |